JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimes, A. S.
Right arrow Articles by London, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimes, A. S.
Right arrow Articles by London, E. D.

Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal

AS Kimes and ED London

Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland.

Rates of local cerebral glucose utilization (LCGU) were measured in morphine-dependent and morphine-abstinent rats. Morphine pellets were implanted s.c. (one pellet 7 days before glucose utilization measurement and two pellets 4 days before the measurement) to produce opioid dependence. LCGU rates in 85 brain regions of placebo- and morphine-pelleted rats were similar. In contrast, LCGU rates, 5 hr after implantation of one morphine pellet, were decreased significantly in six areas. The lack of a chronic morphine effect on LCGU suggests tolerance to morphine. Additional support for this view was that an additional dose of morphine (8 mg/kg s.c.) in morphine-dependent rats was also ineffective in altering LCGU and in an antinociception (hot plate) test. Furthermore, plasma morphine levels in chronically treated animals were greater than those in acutely treated animals. Naloxone- precipitated morphine withdrawal enhanced LCGU, most notably in thalamic and limbic areas, but also in some hypothalamic and hindbrain regions. The findings identify brain areas that may be important in the opioid abstinence syndrome. Furthermore they suggest that adaptations in the brain produce tolerance to morphine, reflected in LCGU rates and latencies in the hot-plate test.

Volume 248, Issue 2, pp. 538-545, 02/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Neurosci.Home page
M. Alreja, M. Shanabrough, W. Liu, and C. Leranth
Opioids Suppress IPSCs in Neurons of the Rat Medial Septum/Diagonal Band of Broca: Involvement of {micro}-Opioid Receptors and Septohippocampal GABAergic Neurons
J. Neurosci., February 1, 2000; 20(3): 1179 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. Tao, Z. Ma, and S. B. Auerbach
Alteration in Regulation of Serotonin Release in Rat Dorsal Raphe Nucleus after Prolonged Exposure to Morphine
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 481 - 488.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
B. Chieng and M. J. Christie
Local Opioid Withdrawal in Rat Single Periaqueductal Gray Neurons In Vitro
J. Neurosci., November 15, 1996; 16(22): 7128 - 7136.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics.